Kirkland & Ellis is advising China International Capital Corporation Hong Kong Securities Limited on the transaction.Shanghai Fosun New Medicine Research Company Limited, a wholly-owned subsidiary of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
